As shown in Figure 5b, 29 days post-implantation, tumor sizes were significantly smaller in the NAB2–STAT6 CasRx-treated mice (1340.7 mm3 compared to 2963.4 mm3 for PBS-treated mice, p-value < 0.05), which were corroborated by high-resolution computed tomography (CT) scans with axial and sagittal views of the tumors prior to excision (Figure 5c). This evidence concerns the gene STAT6 and neoplasm.